Basel, 6 December 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced its plans to launch the SARS-CoV-2 & Flu A/B Rapid Antigen Test for professional use in markets accepting the CE Mark by the ...
In a study involving nearly 1,000 patients seen at a Baltimore field hospital during a five-month period in 2022, researchers at Johns Hopkins Medicine, the University of Maryland School of Medicine, ...
Engineered M13 phage-based biosensor offers rapid, label-free detection of SARS-CoV-2 spike protein, demonstrating femtogram-level sensitivity in tests.
The CLINITEST Rapid COVID-19 Antigen Self-Test has received FDA EUA for unsupervised self-testing for the SARS-CoV-2 virus by individuals age 14 and older (or adult-collected samples from individuals ...
Households will be able to obtain four free antigen COVID-19 tests by visiting COVIDtests.gov, and filling out their name and shipping address, a repeat of the 2023 program. And the department says ...
CARLSBAD, Calif., March 19, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the ...
The granting of emergency use authorization by the U.S. FDA to Roche AG for its four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and respiratory syncytial virus will allow the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results